Natural antioxidants for non‐alcoholic fatty liver disease: molecular targets and clinical perspectives
-
- Federico Salomone
- Division of Gastroenterology Ospedale di Acireale Azienda Sanitaria Provinciale di Catania Catania Italy
-
- Justyna Godos
- Department of Biomedical and Biotechnological Sciences University of Catania Catania Italy
-
- Shira Zelber‐Sagi
- The Liver Unit Gastroenterology Department Tel‐Aviv Medical Center Tel Aviv Israel
書誌事項
- 公開日
- 2015-11-05
- 権利情報
-
- http://onlinelibrary.wiley.com/termsAndConditions#vor
- DOI
-
- 10.1111/liv.12975
- 公開者
- Wiley
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>Non‐alcoholic steatohepatitis (<jats:styled-content style="fixed-case">NASH</jats:styled-content>), the progressive form of non‐alcoholic fatty liver disease (<jats:styled-content style="fixed-case">NAFLD</jats:styled-content>), is emerging as a main health problem in industrialized countries. Lifestyle modifications are effective in the treatment of <jats:styled-content style="fixed-case">NAFLD</jats:styled-content>; however, the long‐term compliance is low. Therefore, several pharmacological treatments have been proposed but none has shown significant efficacy or long‐term safety. Natural polyphenols are a heterogeneous class of polyphenolic compounds contained in vegetables, which are being proposed for the treatment of different metabolic disorders. Although the beneficial effect of these compounds has traditionally related to their antioxidant properties, they also exert several beneficial effects on hepatic and extra‐hepatic glucose and lipid homeostasis. Furthermore, natural polyphenols exert antifibrogenic and antitumoural effects in animal models, which appear relevant from a clinical point of view because of the association of <jats:styled-content style="fixed-case">NASH</jats:styled-content> with cirrhosis and hepatocellular carcinoma. Several polyphenols, such anthocyanins, curcumin and resveratrol and those present in coffee, tea, soy are available in the diet and their consumption can be proposed as part of a healthy diet for the treatment of <jats:styled-content style="fixed-case">NAFLD</jats:styled-content>. Other phenolic compounds, such as silymarin, are commonly consumed worldwide as nutraceuticals or food supplements. Natural antioxidants are reported to have beneficial effects in preclinical models of <jats:styled-content style="fixed-case">NAFLD</jats:styled-content> and in pilot clinical trials, and thus need clinical evaluation. In this review, we summarize the existing evidence regarding the potential role of natural antioxidants in the treatment of <jats:styled-content style="fixed-case">NAFLD</jats:styled-content> and examine possible future clinical applications.</jats:p>
収録刊行物
-
- Liver International
-
Liver International 36 (1), 5-20, 2015-11-05
Wiley